FEB 25, 2019 6:44 PM PST

ADHD Drug Holds No Effect on Primate Prefrontal Cortex

WRITTEN BY: Nouran Amin

According to a new research study published eNeuro, investigations of methylphenidate (Ritalin) on neuronal activity in monkeys held no effects on the prefontal cortex unlike studies on mice and rats. The study opens the door to new questions behind why Ritalin improves attention in humans.

In the paper “The effects of methylphenidate (Ritalin) on the neurophysiology of the monkey caudal prefrontal cortex”, researchers refute their hypothesis that the caudal prefrontal cortex, a brain region critical for attention, is drugs main site of action in the brain.

Learn more about brain anatomy:

To conclude their studies, the researcher’s recorded large populations of neurons in the caudal prefrontal cortex region where two male macaque monkeys performed a demanding visual attention task. After administration of the drug, the researchers did not observe any significant differences in neuronal activity in comparison to the placebo, even at doses that improved the monkeys' performance on the task.

Such negative results do not push out any evidence that other regions of the prefrontal cortex could serve as possible sources of Ritalin's action in the brain. Additionally, the study highlights the challenges associated with translating preclinical research from rodents to nonhuman primates and the need for improved partnerships between scientists investigating common questions and using different animal models.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 22, 2019
Health & Medicine
NOV 22, 2019
Federal Government Weighs in on Marijuana and Opioid Addiction
The U.S. government is weighing in on the hot topic of whether or not medical marijuana is a successful tool in treating opioid addiction by barring the us...
NOV 28, 2019
Drug Discovery & Development
NOV 28, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
DEC 08, 2019
Drug Discovery & Development
DEC 08, 2019
Parkinson's Drug Reduces Hallucinations in Dementia Patients
Pimavanserin, also known as Nuplazid, was approved in the US to treat Parkinson’s-related psychosis in 2016. Now, new research has shown that it also...
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Drug Candidates for Alzheimer Disease May Reverse Effects of Aging
Researchers using mouse models of Alzheimer disease were able to demonstrate that the investigational drug candidates ‘CMS121’ and ‘J147&...
DEC 19, 2019
Technology
DEC 19, 2019
Can a 'Lemon' help develop new drugs?
Although artificial intelligence has many advantages in the drug discovery process, challenges still remain--one being the ability for machine learning to ...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
Loading Comments...